Biontech Se Sponsored Adr Stock News

Pfizer and BioNTech are extending a rolling submission to the FDA to include children 6 months to under 5-years-old in their Emergency Use Authorization for their COVID-19 vaccine.

Pfizer Inc. and BioNTech SE said Friday they are continuing to test their COVID-19 vaccine in children between the ages of 6 months old and 4 years old and will now wait until April when they believe they will have clinical data evaluating three doses to seek emergency authorization in the U.S. This announcement comes less than two weeks after the companies submitted an application for emergency authorization to the Food and Drug Administration for this age group based on data using the first two out of three doses. At that time, Pfizer CEO Albert Bourla said in a news release: "If two doses are authorized, parents will have the opportunity to begin a COVID-19 vaccination series for their children while awaiting potential authorization of a third dose." An FDA advisory committee was then scheduled to meet on Tuesday to discuss whether the benefits of the vaccine outweigh the risks among young children. (The FDA said Friday that the meeting has been postponed.) Over the past year, Pfizer''s stock has gained 46.3%, while BioNTech''s shares are up 44.0%.

The US Food and Drug Administration announced Friday that it is postponing the meeting of its Vaccines and Related Biological Products Advisory Committee, originally scheduled for February 15, as "new data have recently emerged" regarding Pfizer and BioNTech''s emergency use authorization request for their Covid-19 vaccine for children younger than 5.

Pfizer and BioNTech on Friday said they are delaying their request for the Food and Drug Administration to authorize the vaccine for children under five years old, because there''s not enough data on the efficacy of a third dose.An FDA advisory panel

Pfizer and BioNTech on Friday said they were delaying their request for the Food and Drug Administration to authorize the vaccine for children under 5 until at least April, as they wait for data on the efficacy of a third dose.

The European Medicines Agency''s safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation after COVID-19 vaccines from Pfizer Inc (NYSE: PFE ) / BioNTech SE (NASDAQ: BNTX ), and Moderna Inc (NASDAQ: MRNA ). The assessment was because of reports of menstrual disorders after receiving both vaccines, and it was not yet clear … Full story available on Benzinga.com

A British Medical Journal investigation has found BioNTech, Pfizer’s partner on the main vaccine supplied in SA, allegedly tried to undermine efforts by the WHO

Parents of kids aged 0-5 will have to wait until at least April for a vaccine. Pfizer will keep testing a 3-dose regimen, nixing plans for 2 doses.

A European Medicines Agency safety committee is investigating cases of menstrual disorders seen with mRNA COVID-19 vaccines made by Pfizer /BioNTech and Moderna.

The European Medicines Agency''s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation with COVID-19 vaccines from Pfizer/BioNTech and Moderna .

The U.S. government is planning a COVID-19 vaccine roll out for children under the age of 5 as soon as February 21, according to a document from the U.S. Centers for Disease Control and Prevention . The FDA is considering authorizing the use of the Pfizer Inc (NYSE: PFE ) - BioNTech SE''s (NASDAQ: BNTX ) COVID-19 vaccine in the age group even though it did not meet a key target in a … Full story available on Benzinga.com

The U.S. government is planning a COVID-19 vaccine roll out for children under the age of 5 as soon as February 21, according to a document from the U.S. Centers for Disease Control and Prevention. G

The U.S. government is planning to roll out COVID-19 shots for children under the age of 5 as soon as Feb. 21, according to a document from the U.S. Centers for Disease Control and Prevention. The U.S. Food and Drug Administration (FDA) is considering authorizing the use of the Pfizer Inc (PFE.N) and BioNTech SE [] The post US Begins Vaccine Rollout For Children Under 5 appeared first on Uzalendo News .

Documents show how a biotech giant aimed to exploit regulatory framework and shipping-container setup to send vaccines from Africa to Europe.

Ahead of the FDA review of Pfizer (PFE)/BioNTech <> COVID-19 vaccine for children aged six months – four years, the U.S